Newsletter Current page: 7

With the Super High Pressure PTCA Balloon, SIS Medical AG manufactures a top product for interventional cardiology. This high-pressure balloon catheter can be used to treat calcified or severely calcified vessels and also in-stent restenosis. Now SIS is pleased to announce that it has been able to recruit Ron Waksman of MedStar Washington Hospital Center, […]

The last two years have clearly shown how important technical suppliers are to the healthcare industry. SHS is therefore pleased to announce a successful investment in a technologically leading Danish medium-sized company in the supply chain field. Lowenco A/S has been developing, producing and installing high-tech ultra-low temperature storage solutions for the biopharma industry since […]

With its investment in the fast-growing French genomics expert PathoQuest SAS, SHS is investing in neighbouring France for the first time. PathoQuest is a spin-off of the Institut Pasteur, one of the world’s leading centres for basic research in biology and medicine. PathoQuest plays a leading role in Europe in the field of quality control […]

For almost two years now, the Corona pandemic has had a massive impact on our lives and also on the economy. This is shown by the small dampener of 0.3 percentage points that the SHS Medical Technology Index had to accept in 2020. Compared to the economy as a whole, however, this decline is moderate […]

The Leipzig-based enzyme producer c-LEcta GmbH is one of the fastest growing biotech companies. Among c-LEcta’s customers are manufacturers of corona vaccines as well as the who’s who of global pharmaceutical and food companies. A real success story, to which SHS has also contributed its share. Now SHS has sold its shares in c-LEcta to […]

In January 2021, SHS sold its shares in the Austrian life science supplier Single Use Support GmbH (SUS). The patent-protected liquid logistics system developed by SUS is considered the gold standard today. Among other things, SHS established a scalable corporate organisation at SUS and optimised the supply chains. During the investment phase, SUS multiplied its […]

Private equity: high-yield investment as part of diversification In turbulent times like these, when a lot of money is looking for attractive investment opportunities, private equity is more popular than ever as an investment form among institutional investors. Even in 2020, when the world was hit by the Corona pandemic, there were more than 8000 […]

SHS has been an official member of the United Nations Initiative for Responsible Investment, or UN PRI, since September 2021. What does UN PRI membership mean for SHS? Dr André Zimmermann (Partner and Head of ESG at SHS): As a specialised healthcare investor, SHS has been investing according to ethical standards for more than 25 […]

An interview with Dr Hanno Kühn, Chief Investment Officer (CIO) and head of apoBank’s institutional investment business, and Hubertus Leonhardt, Managing Director and partner of SHS Gesellschaft für Beteiligungsmanagement mbH. Düsseldorf and Tübingen , 22.7.2021 As the largest cooperative primary bank in Germany, apoBank is the number one financial services provider in the health care […]

Experience for the future: Internships at SHS | We offer students a practical experience | private equity and growth companies – learn more!

History of depression “Anxiety and terror by night as well as by day, sleeplessness, blunders, errors, misplaced worries, lack of insight into the actual situation and acting contrary to habit …” – this is how Hippocrates, the most famous physician of antiquity, described depression, which at that time was still called melancholia. The name depression […]

Here we introduce you to the SHS senior advisors. The experience of these experts plays an important role for us in the investment process and benefits not least our portfolio companies. Prof. Dr. med. Marc O. Schurr has been Senior Advisor to SHS since 2020. A graduate in human medicine, he is the founder and […]